UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Darling Ingredients
DAR
$9.28B
| $43.6M | 0.01% |
1,185,557
+583,531
| +97% | +$24.2M |
|
1127
PUT
MetLife
MET
$61.6B
| $43.6M | 0.01% |
620,600
+170,600
| +38% | +$12.2M |
|
1128
PUT
Rivian
RIVN
$22.3B
| $43.6M | 0.01% |
3,245,700
+373,100
| +13% | +$3.9M |
|
1129
Bunge Global
BG
$20.5B
| $43.5M | 0.01% |
407,634
+12,344
| +3% | +$1.29M |
|
1130
Pentair
PNR
$10.9B
| $43.5M | 0.01% |
567,375
+93,970
| +20% | +$7.57M |
|
1131
PUT
iShares US Real Estate ETF
IYR
$4.66B
| $43.5M | 0.01% |
495,700
+178,400
| +56% | +$15.3M |
|
|
P
1132
Everpure Inc
P
$28B
| $43.4M | 0.01% |
675,132
+193,367
| +40% | +$11.2M |
|
1133
Canadian Natural Resources
CNQ
$95.5B
| $43.3M | 0.01% |
1,215,490
+134,938
| +12% | +$5.08M |
|
1134
Canadian National Railway
CNI
$77B
| $43.2M | 0.01% |
365,892
+23,592
| +7% | +$2.95M |
|
1135
CALL
TripAdvisor
TRIP
$1.61B
| $43.1M | 0.01% |
2,422,210
+1,546,810
| +177% | +$33.5M |
|
1136
Qorvo
QRVO
$8.33B
| $43M | 0.01% |
370,621
-97,275
| -21% | -$10.4M |
|
1137
McCormick & Company Non-Voting
MKC
$14.1B
| $43M | 0.01% |
605,670
-285,072
| -32% | -$20.7M |
|
1138
CALL
Take-Two Interactive
TTWO
$44B
| $43M | 0.01% |
276,300
-83,000
| -23% | -$12.6M |
|
1139
Loews
L
$23.6B
| $43M | 0.01% |
574,694
-64,879
| -10% | -$4.92M |
|
1140
JD.com
JD
$44.1B
| $42.9M | 0.01% |
1,660,086
+665,049
| +67% | +$19.5M |
|
1141
Quest Diagnostics
DGX
$26.1B
| $42.9M | 0.01% |
313,104
-6,274
| -2% | -$859K |
|
1142
PUT
Moderna
MRNA
$22.7B
| $42.8M | 0.01% |
360,800
-17,900
| -5% | -$2.27M |
|
1143
Kanzhun
BZ
$7.26B
| $42.8M | 0.01% |
2,277,175
+10,572
| +0.5% | +$213K |
|
1144
CALL
ASML
ASML
$648B
| $42.6M | 0.01% |
41,652
-18,004
| -30% | -$17.3M |
|
1145
Cincinnati Financial
CINF
$27.3B
| $42.5M | 0.01% |
360,258
-184,379
| -34% | -$21.6M |
|
1146
Invesco S&P 500 GARP ETF
SPGP
$2.31B
| $42.4M | 0.01% |
412,564
-17,877
| -4% | -$1.84M |
|
1147
Veeva Systems
VEEV
$34.4B
| $42.4M | 0.01% |
231,606
+52,016
| +29% | +$10.3M |
|
1148
Toronto Dominion Bank
TD
$200B
| $42.3M | 0.01% |
770,534
-297,117
| -28% | -$16.8M |
|
1149
First Trust North American Energy Infrastructure Fund
EMLP
$4.09B
| $42.3M | 0.01% |
1,388,713
+36,233
| +3% | +$1.09M |
|
1150
PUT
Lam Research
LRCX
$391B
| $42.3M | 0.01% |
397,000
-24,000
| -6% | -$2.3M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.